Literature DB >> 16364846

Early institution of mechanical support improves outcomes in primary cardiac allograft failure.

Silvana F Marasco1, Donald S Esmore, Justin Negri, Michael Rowland, Andrew Newcomb, Franklin L Rosenfeldt, Michael Bailey, Meroula Richardson.   

Abstract

BACKGROUND: Primary graft failure (PGF) is the leading cause of early mortality after cardiac transplantation, accounting for 27.1% of deaths within 30 days. PGF is defined as severe dysfunction of the cardiac allograft without any obvious anatomic or immunological cause. The purpose of this study was to analyze our last 9 years of experience with cardiac transplantation to determine predictors of PGF and the influence on survival of our policy of early institution of mechanical circulatory support (MCS) in these patients.
METHODS: Data on 214 consecutive cardiac transplants performed at The Alfred Hospital between January 1996 and August 2004 were reviewed. PGF was defined as right or left or biventricular failure manifesting as hypotension (systolic blood pressure <90 mm Hg), low cardiac output (cardiac index <2.0 liter/min/m2 and pulmonary capillary wedge pressure >20 mm Hg after coming off cardiopulmonary bypass despite inotropic support of up to 5 mug/min adrenaline and without any other obvious cause for the graft dysfunction.
RESULTS: PGF developed in 51 patients (24%). Significant factors in the development of PGF were long ischemic time, which became significant over 4 hours (odds ratio, 1.43; p = 0.01) and increased donor age (odds ratio, 1.027; p = 0.045). Fifteen patients required mechanical support, and of these, 10 survived to leave hospital.
CONCLUSIONS: PGF is the major cause of early mortality after cardiac transplantation. Significant risks for PGF are long allograft ischemic time and increased donor age. Once the patient has survived 30 days, however, the longer-term survival is not influenced by PGF. Our management strategy of early mechanical support has yielded good outcomes in this population with a high risk of early death.

Entities:  

Mesh:

Year:  2005        PMID: 16364846     DOI: 10.1016/j.healun.2005.06.007

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  17 in total

1.  Ambulatory extracorporeal membrane oxygenation with subclavian venoarterial cannulation to increase mobility and recovery in a patient awaiting cardiac transplantation.

Authors:  Samuel Jacob; Juan C MacHannaford; Themistokles Chamogeorgakis; Gonzalo V Gonzalez-Stawinski; Joost Felius; Aldo E Rafael; Rajasekhar S Malyala; Brian Lima
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

2.  Salvage of severe primary graft dysfunction following heart transplantation using extracorporeal life support.

Authors:  Katalin Martits-Chalangari; Omar Hernandez; Aayla K Jamil; Huanying Qin; Joost Felius; Samuel Jacob; Brian Lima; Aldo Rafael; Gonzalo V Gonzalez-Stawinski; Melody J Sherwood; Shelley A Hall
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-10-18

3.  Incidence, etiology, and outcome of primary graft dysfunction in adult heart transplant recipients: a single-center experience in Japan.

Authors:  Osamu Seguchi; Tomoyuki Fujita; Yoshihiro Murata; Haruki Sunami; Takuma Sato; Takuya Watanabe; Seiko Nakajima; Kensuke Kuroda; Eriko Hisamatsu; Takamasa Sato; Masanobu Yanase; Hiroki Hata; Kyoichi Wada; Hatsue Ishibashi-Ueda; Junjiro Kobayashi; Takeshi Nakatani
Journal:  Heart Vessels       Date:  2015-02-15       Impact factor: 2.037

4.  Mechanical circulatory support after heart transplantation.

Authors:  Tomislav Mihaljevic; Craig M Jarrett; Gonzalo Gonzalez-Stawinski; Nicholas G Smedira; Edward R Nowicki; Lucy Thuita; Maria Mountis; Eugene H Blackstone
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

5.  Should heart transplant recipients with early graft failure be considered for retransplantation?

Authors:  Alexander Iribarne; Kimberly N Hong; Rachel Easterwood; Jonathan Yang; Valluvam Jeevanandam; Yoshifumi Naka; Mark J Russo
Journal:  Ann Thorac Surg       Date:  2011-09       Impact factor: 4.330

Review 6.  Extra Corporeal Membrane Oxygenation (ECMO) review of a lifesaving technology.

Authors:  George Makdisi; I-Wen Wang
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

Review 7.  A state-of-the-art review of the current role of cardioprotective techniques in cardiac transplantation.

Authors:  Paul P Cullen; Steven S Tsui; Noel M Caplice; John A Hinchion
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-05-10

8.  Primary graft failure after heart transplantation.

Authors:  Arjun Iyer; Gayathri Kumarasinghe; Mark Hicks; Alasdair Watson; Ling Gao; Aoife Doyle; Anne Keogh; Eugene Kotlyar; Christopher Hayward; Kumud Dhital; Emily Granger; Paul Jansz; Roger Pye; Phillip Spratt; Peter Simon Macdonald
Journal:  J Transplant       Date:  2011-08-01

Review 9.  Anaesthesia for heart transplantation.

Authors:  S Edwards; S Allen; D Sidebotham
Journal:  BJA Educ       Date:  2021-04-27

10.  Experience of ECMO in primary graft dysfunction after orthotopic heart transplantation.

Authors:  Elson Borges Lima; Claudio Ribeiro da Cunha; Vitor Salvatore Barzilai; Marcelo Botelho Ulhoa; Maria Regina de Barros; Camila Scatolin Moraes; Letycia Chagas Fortaleza; Nubia Wellerson Vieira; Fernando Antibas Atik
Journal:  Arq Bras Cardiol       Date:  2015-07-21       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.